ZEB1 and multiple sclerosis: ZEB1 suppression in T-cells alleviates the development and severity of symptoms in an animal model of autoimmune inflammatory diseases, while the downregulation of ZEB1 reduces pathogenic cytokine expression in T-cells from patients with multiple sclerosis [44].